mono-N-demethyladinazolam

Known as: N-desmethyladinazolam mesylate, mono-N-demethyladinazolam mesylate, N-desmethyladinozolam 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1990-1998
02419901998

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
The kinetics of the N-demethylation of adinazolam to N-desmethyladinazolam (NDMAD), and of NDMAD to didesmethyladinazolam (DDMAD… (More)
Is this relevant?
1994
1994
The pharmacokinetics and pharmacodynamics of adinazolam and N-demethyladinazolam (NDMAD) were evaluated in twelve healthy non… (More)
Is this relevant?
1994
1994
The effects of probenecid (2 gm) on the pharmacokinetics, pharmacodynamics, and uricosuric effects of adinazolam and N… (More)
Is this relevant?
1993
1993
Adinazolam is a triazolobenzodiazepine, currently under clinical investigation, that possesses antidepressant and anxiolytic… (More)
Is this relevant?
1992
1992
The tolerability, pharmacokinetics and pharmacodynamics of adinazolam and N-desmethyladinazolam (NDMAD) were assessed following… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 5
Is this relevant?
1992
1992
The pharmacokinetics and pharmacodynamics of adinazolam and N-desmethyladinazolam were studied in 18 young subjects, from 21 to… (More)
Is this relevant?
1992
1992
The effect of adinazolam release rate on psychomotor performance and sedation was assessed by administering 40 mg adinazolam… (More)
Is this relevant?
1992
1992
Adinazolam is a triazolobenzodiazepine with anxiolytic and antidepressant activity. Adinazolam is metabolized extensively; the… (More)
Is this relevant?
1991
1991
Results of previous studies suggest that N-desmethyladinazolam, the major metabolite of adinazolam in man, contributes… (More)
  • table 1
  • table 2
  • figure 1
Is this relevant?
1990
1990
The tolerance, pharmacokinetics, and pharmacodynamics of adinazolam and N-desmethyladinazolam (NDMAD) were assessed after single… (More)
Is this relevant?